12:00 AM
 | 
Dec 24, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BSD-2000 Hyperthermia System: Phase I/II started

BSD began the open-label, German Phase I/II HyRec trial to evaluate the BSD-2000 Hyperthermia System in combination with 5-fluorouracil (5-FU) and oxaliplatin chemotherapy and radiotherapy in about 59 patients. BSD-2000 has Humanitarian Device...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >